EUVIMEDEUVIMED entdecken
Crossref

Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy

Kazushige Kawai, Kosuke Ozaki, Daisuke Nakano, Akira Dejima, Ichiro Ise, Sakiko Nakamori, Hiroki Kato, Soichiro Natsume, Misato Takao, Tatsuro Yamaguchi, Soichiro Ishihara

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02520-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Kazushige Kawai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Honkomagome 3-18-22, Bunkyo-ku, Tokyo,…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Neoplasm Staging, Chemoradiotherapy. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Grants-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The neoadjuvant rectal score (NAR score) has recently been proposed as a better prognostic model than the conventional TNM classification for rectal cancer patients that have undergone neoadjuvant chemoradiotherapy. We recently developed an apoptosis-detection technique for assessing the viability of residual tumors in resected specimens after chemoradiotherapy. This study aimed to establish an improved prognostic classification by combining the NAR score and the assessment of the apoptosis of residual cancer cells. METHODS: We retrospectively enrolled 319 rectal cancer patients who underwent chemoradiotherapy followed by radical surgery. The recurrence-free survival and overall survival of the four models were compared: TNM stage, NAR score, modified TNM stage by re-staging according to cancer cell viability, and modified NAR score also by re-staging. RESULTS: Downstaging of the ypT stage was observed in 15.5% of cases, whereas only 4.5% showed downstaging of ypN stage. C-index was highest for the modified NAR score (0.715), followed by the modified TNM, TNM, and NAR score. Similarly, Akaike's information criterion was smallest in the modified NAR score (926.2), followed by modified TNM, TNM, and NAR score, suggesting that the modified NAR score was the best among these four models. The overall survival results were similar: C-index was the highest (0.767) and Akaike's information criterion was the smallest (383.9) for the modified NAR score among the four models tested. CONCLUSION: We established a novel prognostic model, for rectal cancer patients that have undergone neoadjuvant chemoradiotherapy, using a combination of apoptosis-detecting immunohistochemistry and neoadjuvant rectal scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyNeoplasm StagingChemoradiotherapyHumansMaleFemaleMiddle AgedAgedPrognosisRetrospective StudiesAdultApoptosisDisease-Free SurvivalAged, 80 and over

Stichwörter der Autor:innen

ApoptosisChemoradiotherapyNeoadjuvant rectal scorePrognosisRectal cancer

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Honkomagome 3-18-22, Bunkyo-ku, Tokyo, 113-8677, Japan. kz-kawai@mvd.biglobe.ne.jp.
  • Department of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Honkomagome 3-18-22, Bunkyo-ku, Tokyo, 113-8677, Japan.

Förderung

  • Grants-in-Aid for Scientific Research

Zitieren

APA

Kawai, K., Ozaki, K., Nakano, D., Dejima, A., Ise, I., Nakamori, S., Kato, H., Natsume, S., Takao, M., Yamaguchi, T., & Ishihara, S. (2024). Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02520-4

Vancouver

Kawai K, Ozaki K, Nakano D, Dejima A, Ise I, Nakamori S, et al. Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02520-4

BibTeX
@article{Kawai2024,
  author = {Kawai, Kazushige and Ozaki, Kosuke and Nakano, Daisuke and Dejima, Akira and Ise, Ichiro and Nakamori, Sakiko and Kato, Hiroki and Natsume, Soichiro and Takao, Misato and Yamaguchi, Tatsuro and Ishihara, Soichiro},
  title = {Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02520-4}
}
Kostenlos starten →